centurium – Page 5 – 大钲资本

Centurium Capital Closes Its Debut Dollar Fund at Over US$2 Billion

Posted on 2019年7月3日2023年9月5日 by centurium

Beijing, China, July 3, 2019 – Centurium Capital, a leading private equity firm in China, today announced the successful close of its debut US dollar fund, Centurium Capital Partners 2018 L.P. at over US$2 billion, far exceeding its target size. The fund has secured overwhelming interests from global institutional investors including pension funds, sovereign wealth funds, family offices, corporate pensions, FOFs, and other financial institutions. The fund was launched in March 2018 and reached a significant first close of nearly US$1 billion in June 2018.

Centurium Capital primarily focuses on investing into China’s consumer, services and healthcare sectors. The firm’s investment theses are built around its core investment strategy of “invest to transform”. Centurium seeks to invest in control or significant minority private equity stakes with a particular focus on in-depth engagement to improve operational efficiency and solve structural deficiencies.

David Li, Chairman and CEO of Centurium Capital, commented, “The successful fundraise is a vote of confidence in China’s long term growth potential by global investors, as well as a strong testament to our firm’s strategy and ability of investing to transform. In the context of China’s new norm of economic growth model and fast-evolving business landscape, Chinese companies and entrepreneurs are faced with unprecedented new challenges as well as new opportunities. With a unique combination of global best practice and local expertise and experience, Centurium Capital is well positioned to provide bespoke solutions to these challenges and opportunities by being a long term partner of capital and mindshare to our portfolio companies and entrepreneurs”.

Since its first close, Centurium Capital has made a number of investments, including Luckin Coffee (NASDAQ: LK), a leading internet based on demand coffee brand and retail chain in China, China Biologic Products (NASDAQ: CBPO), one of the largest plasma-based biopharmaceutical companies in China, and LOHO, China’s leading fast-fashion eyewear brand and retailer with a vertically integrated supply chain.

Qlife

Posted on 2021年10月25日2022年3月17日 by centurium

Qlife is a biomedical company developing high throughput mass spectrometry technology, which is fully Qlife is a biomedical company developing high throughput mass spectrometry technology, which is fully incorporated into omics study to drive for innovative medical laboratory tests and diagnosis. With headquarters in Shanghai and five regional laboratory service centers strategically located in China, Qlife offers innovative metabolomics/proteomics-based assays and laboratory diagnostic tests to enable early prevention and intervention of a variety of diseases. The R&D of Qlife is at the heart of the emerging fields of metabolomics and proteomics. Its proprietary platform and exclusive bioinformatics solutions are at the frontiers to deliver biomarker discoveries and innovative diagnostic tests, as well as aiming to make breakthroughs in precision medicine.

Ruhlamat

Posted on 2025年5月12日2025年5月13日 by centurium

Ruhlamat Group was founded in Germany and established its China headquarters in Suzhou in 1998. Over the past two decades since its inception, Ruhlamat Group has developed a global presence with operations with nine production centers, two technical service centers in Romania, the Czech Republic, India, Mexico and China. Ruhlamat was acquired by Centurium Capital in 2025.

Ruhlamat’s business covers automation solutions, digital solutions, and standard products (servo presses, conveyor systems, and industrial aluminum profiles). Integrating the entire process of process R&D, design, assembly, testing, sales, and service, it provides end-to-end solutions for clients in traditional automotive parts, new energy vehicle components, hydrogen energy, medical and consumer electronics, home appliances, and other general industrial sectors in over 20 countries and regions across Europe, the Americas, and Asia-Pacific.

Sinotau Pharmaceutical

Posted on 2021年10月25日2021年10月25日 by centurium

Sinotau Pharmaceutical is an innovative pharmaceutical company focusing on the R&D, production and clinical application of a new generation of radiopharmaceuticals. Headquartered in Beijing, the company has set up radiopharmaceutical production bases in Jiangsu, Guangdong and Sichuan, and branches in the United States. Leveraging the world’s leading R&D resources in the field of radiopharmaceuticals and precision diagnosis and treatment, Sinotau has taken the lead in deploying a variety of targeted therapies and precision diagnostic radiopharmaceuticals in the fields of tumors, neurodegenerative diseases and cardiovascular diseases. The company’s pipeline has deployed multiple radiological diagnostic and therapeutic products, some of which have entered the stage of registered clinical research.

Yigoli

Posted on 2020年7月20日2024年3月12日 by centurium

Yigoli is China’s first and leading AI-enabled high-tech car wash solution provider with over 3,000 car wash outlets covering most provinces in China, South Korea, Thailand and Indonesia. Leveraging its self-developed intelligent operation system, Yigoli offers one of the most efficient and environmentally- friendly car wash services for customers in China and abroad.

Yunxuetang

Posted on 2020年2月3日2022年12月21日 by centurium

Yunxuetang is a leading corporate training SaaS and services provider in China. Founded in 2011, Yunxuetang provides one-stop training solutions including SaaS, content development and services to thousands of big corporate clients and nearly 30,000 SMEs, including Fortune 500 companies, Tongrentang, Haidilao, Didi, Luckin Coffee and NIO. Headquartered in Beijing and Suzhou, the company has branch offices in over 20 Chinese cities including Shenzhen and Hangzhou.

Yunxuetang’s total solutions include training infrastructure establishment, training materials development, training program maintenance, data analysis and vendor management to meet increasing demands for more efficient staff training as Chinese companies grow and evolve.